Sign Up Today and Learn More About RefleXion Medical Stock
Invest in or calculate the value of your shares in RefleXion Medical or other pre-IPO companies through EquityZen's platform.
RefleXion Medical Stock (REXM)
Biologically-Guided Radiotherapy Systems for Patients with Cancer
About RefleXion Medical Stock
Founded
2009
Headquarters
Hayward, CA, US
Total Funding
291M
Industries
Software, Artificial Intelligence, Data and Analytics
RefleXion Medical is a privately held medical device company developing the first biology-guided radiation therapy system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize the practice of radiation oncology. Early validation of RefleXion's technology was funded by the National Cancer Institute. RefleXion is backed by premier investors; Sofinnova Partners, KCK, Pfizer, Venrock and Johnson & Johnson Innovation.
RefleXion Medical Press Mentions
Stay in the know about the latest news on RefleXion Medical
RefleXion to Share Groundbreaking Research in 37 Scientific Presentations at the AAPM 2024 Annual Meeting
businesswire • Aug 03, 2024
Radiation therapy company RefleXion Medical raises $105M
radiologybusiness • May 04, 2024
CMS Assigns Accretive Reimbursement for RefleXion's Breakthrough SCINTIX Therapy
finance • Apr 06, 2024
RefleXion inks AI partnership for cancer treatment planning
massdevice • Apr 06, 2024
RefleXion and Limbus AI Announce Technology Integration to Expedite Cancer Treatment Planning
businesswire • Apr 06, 2024
Investors in RefleXion Medical
Discover investors in RefleXion Medical stock and explore their portfolio companies
RefleXion Medical Management
Leadership team at RefleXion Medical
Chief Executive Officer
Todd Powell
Chief Financial Officer
Martyn Webster
Join now and verify your accreditation status to gain access to:
- RefleXion Medical current valuation
- RefleXion Medical stock price
- Available deals in RefleXion Medical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in RefleXion Medical stock?
Accredited investors can buy pre-IPO stock in companies like RefleXion Medical through EquityZen funds. These investments are made available by existing RefleXion Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell RefleXion Medical stock?
Shareholders can sell their RefleXion Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
